News ArchivesRead News
Don't blame Parkinson's disease for addiction: study
Thursday January 10, 2013
Andrew Seaman, Reuters
New York - Despite concerns that Parkinson's patients were more likely to become compulsive gamblers or shoppers, a new study says untreated patients don't have any more addictions than people without the disease.
"It's further evidence that the increased frequency (of addictions) in Parkinson's patients is due to the treatments themselves not the illness," said Dr. Daniel Weintraub, the study's lead author from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia.
In 2010, Weintraub found that people who took certain Parkinson's medications were three times as likely to have impulse control problems such as gambling, binge eating, shopping sprees and compulsive sexual behaviors.
So-called dopamine agonists, such as GlaxoSmithKline's Requip or ropinirole or Boehringer Ingelheim's Mirapex or pramipexole, are meant to stimulate parts of the brain in people with Parkinson's to improve movement, stiffness and tremors.
Patients with the incurable disease have difficulties with movement, muscle control and balance and can eventually become paralyzed and die. The U.S. National Institutes of Health says 500,000 people are thought to have Parkinson's disease, and about 50,000 new cases are reported every year.
For the new study, Weintraub and his colleagues, who published their findings in the journal Neurology, surveyed 168 people with untreated Parkinson's disease and 143 people without the condition.
Each person was asked about - among other things - compulsive gambling, shopping, sexual behaviors and eating.
Overall, there were no significant differences between the two groups when it came to any of the compulsive behaviors.
About 1 percent of participants in each group reported a gambling problem, between 2 and 3 percent a shopping addiction and between 3.5 percent and 4 percent a sexual behavior addiction.
In each group, about 20 percent of participants had an impulse control problem.
"This study seems to support that fact it's related to the medication," said Dr. Anhar Hassan, who was not involved with the new study but researches movement disorders.
According to Hassan, from the Mayo Clinic in Rochester, Minnesota, the link between the Parkinson's drugs and the addictions was first discovered between 2003 and 2004. Since then, she said, it's become a well-known side effect amongst Parkinson's patients.
"It's our routine practice to warn patients that this is a potential side effect when we're starting them on these medications," she said, adding that they screen for the behaviors during checkups.
"There is a potential for these to be quite devastating," she said.
Recent NewsSep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 9 - Parkinson’s Experiment to Be Aboard Next Flight to International Space Station
Aug 9 - Parkinson’s Disease and Sleeping with the Enemy
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement